Estrella Immunopharma, Inc. Quarterly Share-based Payment Arrangement, Expense in USD from Q4 2022 to Q1 2023

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Estrella Immunopharma, Inc. quarterly Share-based Payment Arrangement, Expense history and growth rate from Q4 2022 to Q1 2023.
  • Estrella Immunopharma, Inc. Share-based Payment Arrangement, Expense for the quarter ending March 31, 2023 was $102K.
Share-based Payment Arrangement, Expense, Quarterly (USD)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2023 $102K Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q4 2022 $102K Oct 1, 2022 Dec 31, 2022 10-Q 2024-02-14
* An asterisk sign (*) next to the value indicates that the value is likely invalid.